ask="N/A"
ask_size="N/A"
average_daily_volume="19739"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="+0.10"
change_from_200_day_moving_average="0.42"
change_from_50_day_moving_average="-0.94"
change_from_52_week_high="-2.40"
change_From_52_week_low="2.70"
change_in_percent="+1.83%"
close="5.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.46"
ebitda="-11.23M"
eps_estimate_current_year="-0.42"
eps_estimate_next_quarter="-0.16"
eps_estimate_next_year="-0.50"
ex_dividend_date="N/A"
float_shares="3301000"
high="5.55"
high_52_weeks="7.95"
last_trade_date="2/7/2017"
last_trade_price="5.55"
last_trade_size="587"
last_trade_time="4:45pm"
low="5.31"
low_52_weeks="2.85"
market_capitalization="159.33M"
moving_average_200_day="5.13"
moving_average_50_day="6.49"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="9.67"
open="5.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+8.18%"
percent_change_from_50_day_moving_average="-14.54%"
percent_change_from_52_week_high="-30.19%"
percent_change_from_52_week_low="+94.74%"
previous_close="5.45"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="12.33"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="4.08"
stock_exchange="ASE"
symbol="OCX"
volume="13184"
weeks_range_52="2.85 - 7.95"
